ZIVO Bioscience, Inc. (ZIVO)

USD 16.02

(-15.68%)

Revenue Summary of ZIVO Bioscience, Inc.

  • ZIVO Bioscience, Inc.'s latest annual revenue in 2023 was 27.65 Thousand USD , down 0.0% from previous year.
  • ZIVO Bioscience, Inc.'s latest quarterly revenue in 2024 Q1 was 35.72 Thousand USD , up 202.71% from previous quarter.
  • ZIVO Bioscience, Inc. reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • ZIVO Bioscience, Inc. reported a annual revenue of - USD in annual revenue 2021, down -100.0% from previous year.
  • ZIVO Bioscience, Inc. reported a quarterly revenue of 35.72 Thousand USD for 2024 Q1, up 202.71% from previous quarter.
  • ZIVO Bioscience, Inc. reported a quarterly revenue of - USD for 2023 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of ZIVO Bioscience, Inc. (2023 - 2000)

Historical Annual Revenue of ZIVO Bioscience, Inc. (2023 - 2000)

Year Revenue Revenue Growth
2023 27.65 Thousand USD 0.0%
2022 - USD 0.0%
2021 - USD -100.0%
2020 20 Thousand USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD -100.0%
2011 103.89 Thousand USD 25.59%
2010 82.72 Thousand USD 4.53%
2009 79.14 Thousand USD -55.26%
2008 176.9 Thousand USD 9.65%
2007 161.34 Thousand USD -45.73%
2006 297.29 Thousand USD 209.79%
2005 95.96 Thousand USD 95.62%
2004 49.05 Thousand USD 2820.12%
2003 1680.00 USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%

Peer Revenue Comparison of ZIVO Bioscience, Inc.

Name Revenue Revenue Difference
America Great Health 204.3 Thousand USD 86.467%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
Biora Therapeutics, Inc. 4000.00 USD -591.25%
Bio-Path Holdings, Inc. - USD -Infinity%
Better Therapeutics, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD 95.633%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Evolutionary Genomics, Inc. - USD -Infinity%
Finch Therapeutics Group, Inc. 107 Thousand USD 74.159%
Galera Therapeutics, Inc. - USD -Infinity%
Innovation1 Biotech Inc. - USD -Infinity%
Kiromic BioPharma, Inc. - USD -Infinity%
Molecular Templates, Inc. 57.3 Million USD 99.952%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD 57.884%
NexImmune, Inc. - USD -Infinity%
Orgenesis Inc. 530 Thousand USD 94.783%
Panbela Therapeutics, Inc. - USD -Infinity%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 62.83 Million USD 99.956%
Statera Biopharma, Inc. - USD -Infinity%
TRACON Pharmaceuticals, Inc. 12.04 Million USD 99.77%
Trevena, Inc. 3.12 Million USD 99.115%
Vaxxinity, Inc. - USD -Infinity%
Vaccinex, Inc. 570 Thousand USD 95.149%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%